Ipamorelin Postoperative Ileus Phase 2 Randomized Trial
A phase 2 RCT found ipamorelin was well-tolerated after bowel resection surgery with a favorable adverse event profile, though no significant difference vs placebo on the primary endpoint.
A phase 2 RCT found ipamorelin was well-tolerated after bowel resection surgery with a favorable adverse event profile, though no significant difference vs placebo on the primary endpoint.